Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hormone Therapy
Estrogen and progestin may contribute to gynecologic complications
August 4th, 2005
Study suggests that estrogen and progestin therapy may contribute to gynecologic complications. Researchers in Wisconsin conducted a study to estimate the effects of estrogen plus progestin (E+P) therapy on menopausal symptoms, vaginal bleeding, gynecologic surgery rates, and treatment-related adverse effects in postmenopausal women. They carried out a randomized, double-blind, placebo-controlled trial of 16,608 postmenopausal women, ages 50-79 (mean±standard deviation 63.3±7.1) years, with intact uterus, randomized to one tablet per day containing 0.625 mg conjugated equine estrogens plus 2.5 mg medroxyprogesterone acetate (n=8,506) or...
Source: Women's Health Weekly (2005-08-04)
|
